GeneDx Holdings WGS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from GeneDx Holdings’s reported figures.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's free cash flow?
- GeneDx Holdings (WGS) reported free cash flow of -$38.86M in Q1 2026.
- How has GeneDx Holdings's free cash flow changed year-over-year?
- GeneDx Holdings's free cash flow decreased by 1058.8% year-over-year, from $4.05M to -$38.86M.
- What is the long-term trend for GeneDx Holdings's free cash flow?
- Over 3 years (2021 to 2024), GeneDx Holdings's free cash flow has grown at a -44.6% compound annual growth rate (CAGR), from -$199.83M to -$33.99M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.